Mental disorders frequently begin in childhood or adolescence. Psychotropic medications
have various indications for the treatment of mental disorders in this age group and are used …

People with serious mental illness (SMI), including schizophrenia, bipolar disorder, and
major depressive disorder, have a higher mortality rate and shortened life expectancy. This …

Top‐tier evidence on the safety/tolerability of 80 medications in children/adolescents with
mental disorders has recently been reviewed in this journal. To guide clinical practice, such …

The clinical severity, impact on development, and poor prognosis of childhoodonset
schizophrenia (COS) may represent more homogeneous forms of the disorder. 1, 2 In …

Metabolic side effects of antipsychotic drugs can have serious health consequences and
may increase mortality. Although persons with schizophrenia often take these drugs for a …

Children and adolescents with schizophrenia are a particularly vulnerable group. Thus, we
integrated all the randomized evidence from the available antipsychotics used for this …

Background Clinically significant attention‐deficit/hyperactivity disorder (ADHD) symptoms
are common and impairing in children and youth with autism spectrum disorder (ASD). The …

Abnormal Child and Adolescent Psychology is a comprehensive introduction to the field. It
covers theoretical and methodological foundations and examines the characteristics …

Negative symptoms (such as amotivation and diminished expression) associated with
schizophrenia are a major health concern. Adequate treatment would mean important …

Background Adolescent major depressive disorder (MDD) is a significant health problem,
associated with substantial morbidity, cost, and mortality. Depression is a significant risk …